T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Southern Missouri Bancorp
SMBC
$849M
| $220K | ﹤0.01% |
+3,821
| New | +$235K |
|
2627
Amylyx Pharmaceuticals
AMLX
$2.51B
| $219K | ﹤0.01% |
57,700
+2,100
| +4% | +$9.88K |
|
|
HDSN
2628
Hudson Technologies
HDSN
$239M
| $219K | ﹤0.01% |
39,192
+6,673
| +21% | +$44K |
|
|
DFTX
2629
Definium Therapeutics
DFTX
$5.89B
| $218K | ﹤0.01% |
31,313
+8,361
| +36% | +$57.5K |
|
2630
Petco
WOOF
$822M
| $218K | ﹤0.01% |
57,169
+3,305
| +6% | +$14.9K |
|
2631
Blink Charging
BLNK
$87M
| $217K | ﹤0.01% |
155,833
+35,811
| +30% | +$63.2K |
|
2632
Intuitive Machines
LUNR
$2.83B
| $217K | ﹤0.01% |
+11,896
| New | +$132K |
|
|
SRDX
2633
DELISTED
Surmodics
SRDX
| $217K | ﹤0.01% |
+5,469
| New | +$213K |
|
2634
Frontier Group Holdings
ULCC
$1.56B
| $217K | ﹤0.01% |
30,442
+2,296
| +8% | +$14.3K |
|
2635
KVH Industries
KVHI
$143M
| $216K | ﹤0.01% |
37,763
| – | – |
|
2636
ARKO Corp
ARKO
$505M
| $214K | ﹤0.01% |
32,373
+6,497
| +25% | +$44.7K |
|
|
CTLP
2637
DELISTED
Cantaloupe
CTLP
| $212K | ﹤0.01% |
22,283
+3,462
| +18% | +$31.5K |
|
|
HTBK
2638
DELISTED
Heritage Commerce
HTBK
| $212K | ﹤0.01% |
22,600
+3,234
| +17% | +$32.6K |
|
2639
Evolv Technologies
EVLV
$1.04B
| $211K | ﹤0.01% |
53,225
+10,748
| +25% | +$37.7K |
|
|
MOFG
2640
DELISTED
MidWestOne Financial Group
MOFG
| $211K | ﹤0.01% |
+7,225
| New | +$221K |
|
2641
ARS Pharmaceuticals
SPRY
$608M
| $211K | ﹤0.01% |
19,918
-442,601
| -96% | -$6.2M |
|
2642
i3 Verticals
IIIV
$325M
| $210K | ﹤0.01% |
+9,092
| New | +$213K |
|
|
BBBY
2643
Bed Bath & Beyond
BBBY
$422M
| $209K | ﹤0.01% |
46,450
+17,648
| +61% | +$112K |
|
2644
Climb Global Solutions
CLMB
$531M
| $209K | ﹤0.01% |
+6,580
| New | +$196K |
|
|
EB
2645
DELISTED
Eventbrite
EB
| $209K | ﹤0.01% |
62,076
+5,114
| +9% | +$17K |
|
2646
Phathom Pharmaceuticals
PHAT
$746M
| $209K | ﹤0.01% |
25,641
+4,592
| +22% | +$56.9K |
|
2647
Paysafe
PSFE
$408M
| $209K | ﹤0.01% |
12,207
+1,709
| +16% | +$34.6K |
|
2648
Ring Energy
REI
$344M
| $209K | ﹤0.01% |
153,156
+9,805
| +7% | +$14.7K |
|
|
STRS
2649
DELISTED
STRATUS PPTYS INC
STRS
| $209K | ﹤0.01% |
10,061
+772
| +8% | +$18.6K |
|
|
ETWO
2650
DELISTED
E2open Parent Holdings
ETWO
| $208K | ﹤0.01% |
77,907
+10,321
| +15% | +$32.4K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.